The Directors Team at Tiga TX is responsible for setting the strategic vision, overseeing the development of the IgA therapeutic monoclonal antibody platform, and ensuring alignment across all departments. This team directs high-level decision-making processes and guides the company toward achieving its mission in the treatment of solid tumors.
View all